Condition: Non-small Cell Lung Cancer · Sponsor: Merck Sharp & Dohme LLC
The goal of this study is to evaluate intismeran autogene plus pembrolizumab versus placebo plus pembrolizumab for the adjuvant treatment of margin negative, completely resected Stage II, IIIA, IIIB (with nodal involvement \[N2\]) non-small cell lung cancer (NSCLC). The primary hypothesis is that intismeran autogene plus pembrolizumab is superior to placebo plus pembrolizumab with respect to disease-free survival (DFS) as assessed by the investigator.
This description comes directly from the study's public registry record.
Toll Free Number · 1-888-577-8839 · Trialsites@msd.com
Always discuss trial participation with your own doctor first.
| Alaska Oncology and Hematology ( Site 0039) | Anchorage, Alaska, United States | Recruiting |
| The University of Arizona Cancer Center - North Campus ( Site 0071) | Tucson, Arizona, United States | Recruiting |
| YUMA REGIONAL MEDICAL CENTER CANCER CENTER ( Site 0020) | Yuma, Arizona, United States | Completed |
| UCLA Clinical & Translational Research Center (CTRC) ( Site 0059) | Los Angeles, California, United States | Recruiting |
| Hoag Memorial Hospital Presbyterian ( Site 4042) | Newport Beach, California, United States | Recruiting |
| Hoag Memorial Hospital Presbyterian ( Site 4048) | Newport Beach, California, United States | Recruiting |
| St. Joseph Hospital-The Center for Cancer Prevention and Treatment ( Site 0074) | Orange, California, United States | Recruiting |
| University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 0030) | Orange, California, United States | Recruiting |
| UCHealth Memorial Hospital-Heme Onc ( Site 0052) | Colorado Springs, Colorado, United States | Completed |
| George Washington University Medical Faculty Associates ( Site 4064) | Washington D.C., District of Columbia, United States | Recruiting |
| Mayo Clinic Florida ( Site 4043) | Jacksonville, Florida, United States | Recruiting |
| Miami Cancer Institute at Baptist Health, Inc. ( Site 4047) | Miami, Florida, United States | Recruiting |
+ 217 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.